- RecruitingPHASE3
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
This study compares two treatments, NXT007 and emicizumab, for people aged 12 and over with haemophilia A. It aims to see how well they prevent bleeding, if they are safe, and how they work in the body.
For: Hemophilia AUnited States · Belgium · China - RecruitingPHASE3
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
This study compares a new medicine, NXT007, with standard Factor VIII treatment for people with haemophilia A. It aims to see if NXT007 is safe and works well to prevent bleeding in adults and teenagers aged 12 and older.
For: Hemophilia AUnited States · Germany · Hungary - RecruitingPHASE1, PHASE2
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
This study is testing a new medicine called NXT007 for people with moderate or severe haemophilia A. It's looking at how safe it is, how it works in the body, and if it helps reduce bleeding. Both adults, teenagers, and children can take part.
For: Hemophilia AUnited States · Canada · Italy